About this trial
The aim of the study is to enrich the understanding of the physiological mechanisms that predispose autistic adolescents to mental illness. It will inform a possible pathway and biomarker handprint of mental illness severity and prognosis to formulate a neurobiologically informed personalization strategy that could be applied for selecting appropriate Evidence Based Intervention (EBI) for treating an adolescent formally diagnosed with Autism.
Eligibility criteria
Qualifiers
Autistic Adolescents
Must be able to interact verbally
Parental consent and participants must be able and willing to give written informed assent and to comply with the requirements of the study protocol
Must be willing to return for all study visits and wear the study device at home
Disqualifiers
Adolescents with severe motor impairments or schizophrenia
Complex medical conditions, which would interfere with ability to take part in the study visits or outcomes.
Intellectual disability, not capable to attend mainstream school
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University College Cork
Lead sponsor
University of Southampton
Collaborator
Carol Davila University of Medicine and Pharmacy
Collaborator
Microlink PC UK LTE
Collaborator
Engineering Ingegneria Informatica SpA
Collaborator
MEDEA SRL
Collaborator
ORTHOKEY ITALIA SRL
Collaborator